LivaNova PLC — Company profile
Healthcare · Medical Devices · United Kingdom
Last price 78.97 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 4.35B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories, as well as services related products. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals; and devices that deliver neuromodulation therapy for treating drug-resistant epilepsy and depression. This segment also includes the development and clinical testing of aura6000 system for treating obstructive sleep apnea. It serves perfusionists, neurologists, neurosurgeons, hospitals, other healthcare professionals and medical institutions, and healthcare providers. The company sells its medical devices through direct sales representatives, agents, and independent distributors in the United States, the United Kingdom, Germany, France, Italy, the Netherlands, Spain, Belgium, Poland, Sweden, Switzerland, Austria, Norway, Portugal, Finland, Denmark, and internationally. LivaNova PLC was incorporated in 2015 and is headquartered in Gloucester, the United Kingdom.
Details
| Name | LivaNova PLC |
| Sector | Healthcare |
| Industry | Medical Devices |
| Employees | 3300 |
| Founded | 1987 |
| Ipo Date | 1993-02-10 |
| Ceo | Vladimir Makatsaria |
| Country | United Kingdom |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | GB00BYMT0J19 |
| Cusip | G5509L101 |
| Cik | 0001639691 |
| Sic | 3845 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Vladimir A. Makatsaria | Chief Executive Officer and Director |
| Alex Shvartsburg C.M.A. | Chief Financial Officer |
| Natalia Sergeyevna Kozmina | Chief Human Resources Officer |
| Ahmet Tezel Ph.D. | Chief Innovation Officer |
| Lindsey Little | Vice President and Chief Accounting Officer |
| Briana Gotlin | Vice President of Investor Relations |
| Anne M. Liddy | Chief Legal Officer |
| Deanna Wilke | Vice President of Corporate Communications |
| Philip Kowalczyk | Chief Strategy and Corporate Development Officer |
| Paul R. Buckman | President of Advanced Circulatory Support and GM of Transcatheter Mitral Valve Replacement |
Contact
| Address | 5220 Valiant Court, Gloucester Business Park, Gloucester, GL3 4FE, United Kingdom |
| Phone | 44 1452 638 500 |
| Website | https://www.livanova.com |